MedPath

efficacy of neoadjuvant androgen deprivation therapy fof high risk prostate cancer

Not Applicable
Recruiting
Conditions
prostate cancer
Registration Number
JPRN-UMIN000028874
Lead Sponsor
Fukushima Medical University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

The patients for whom Dutasteride or another androgen deprivation therapy was administrated.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath